Functional CDKN2A assay identifies frequent deleterious alleles misclassified as variants of uncertain significance
- Johns Hopkins University, United States
- The Johns Hopkins University, United States
Abstract
Pathogenic germline CDKN2A variants are associated with an increased risk of pancreatic ductal adenocarcinoma (PDAC). CDKN2A variants of uncertain significance (VUSs) are reported in up to 4.3% of patients with PDAC and result in significant uncertainty for patients and their family members as an unknown fraction are functionally deleterious, and therefore, likely pathogenic. Functional characterization of CDKN2A VUSs is needed to reclassify variants and inform clinical management. 29 germline CDKN2A VUSs previously reported in patients with PDAC or in ClinVar were evaluated using a validated in vitro cell proliferation assay. 12 of the 29 CDKN2A VUSs were functionally deleterious (11 VUSs) or potentially functionally deleterious (1 VUS) and were reclassified as likely pathogenic variants. Thus, over 40% of CDKN2A VUSs identified in patients with PDAC are functionally deleterious and likely pathogenic. When incorporating VUSs found to be functionally deleterious, and reclassified as likely pathogenic, the prevalence of pathogenic/likely pathogenic CDKN2A in patients with PDAC reported in the published literature is increased to up to 4.1% of patients, depending on family history. Therefore, CDKN2A VUSs may play a significant, unappreciated role in risk of pancreatic cancer. These findings have significant implications for the counselling and care of patients and their relatives.
Data availability
All data generated or analysed during this study are included in the manuscript, supporting files, and as Source data and Source code.
Article and author information
Author details
Nicholas Jason Roberts
Funding
The Sol Goldman Pancreatic Cancer Research Center (Pilot Grant)
- Nicholas Jason Roberts
National Institutes of Health (S10 OD026859)
- Nicholas Jason Roberts
The Rolfe Pancreatic Cancer Foundation
- Nicholas Jason Roberts
National Institutes of Health (P50 CA622924)
- Alison P Klein
- Nicholas Jason Roberts
The Japanese Society of Gastroenterology
- Hirokazu Kimura
The Japan Society for Promotion of Science
- Hirokazu Kimura
The Joseph C Monastra Foundation
- Nicholas Jason Roberts
The Geral O Mann Foundation
- Nicholas Jason Roberts
Art Creates Cures Foundation
- Nicholas Jason Roberts
Susan Wojcicki and Denis Troper
- Nicholas Jason Roberts
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Copyright
© 2022, Kimura et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,698
- views
-
- 365
- downloads
-
- 14
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Citations by DOI
-
- 14
- citations for umbrella DOI https://doi.org/10.7554/eLife.71137
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Functional CDKN2A assay identifies frequent deleterious alleles misclassified as variants of uncertain significance
eLife 11:e71137.
https://doi.org/10.7554/eLife.71137
